Description
SR-9009 Stenabolic Injectable Research Overview
Disclaimer: The compounds described on this page are intended for laboratory research use only and are not approved for human consumption.
Overview of SR-9009 Stenabolic
Stenabolic, also known as SR9009, is a synthetic compound. It belongs to a class of REV-ERBα agonists rather than a selective androgen receptor modulator (SARM). It functions by activating REV-ERB proteins. This activation can regulate circadian rhythms that affect sleep cycles, metabolism, and energy balance in research models.
SR-9009 has been observed in preclinical studies to reduce fat mass, improve lipid and glucose profiles, and increase mitochondrial activity in test models. These effects are tied to higher energy use and better circadian rhythm control in research models.
| Section | Details |
|---|---|
| CAS Number | 1379686-30-2 |
| Molar Mass | 437.9 g/mol |
| Chemical Formula | C20H24ClN3O4S |
| IUPAC Name | ethyl 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]pyrrolidine-1-carboxylate ® |
| Synonyms | SR9009, SR-9009, SR 9009, X5DCA09N30, DTXSID901045515 |
| Ingredients / Composition | SR-9009 Stenabolic Injectable contains SR-9009 with a purity of 99.8%. |
| Shelf Life | 12 to 24 months |
| Storage Instructions | SR-9009 Stenabolic Injectable should be stored at 2–8 °C. |
| Disclaimer | SR-9009 Stenabolic is not approved for human use. It is legal for research purposes only. |
Why Consider SR-9009 Stenabolic Injectable for Research?
Researchers may consider SR-9009 Stenabolic Injectable based on its intended research application, available specifications, and supporting documentation.
- Vendor-reported purity of SR-9009 Stenabolic Injectable: 99.8%. Review the vendor’s certificate of analysis for the batch.
- The assay result of this product meets research-grade standards at 98.9%.
- The endotoxin levels present in SR-9009 are measured at <0.2 EU/mL, which is below the specified limit.
- The heavy metal content was tested at <5 ppm, which is well within the required safety range.
- A Certificate of Analysis (COA) is provided for verification.
Frequently Asked Questions
What is the legal status of SR-9009 Stenabolic?
SR-9009 is not FDA-approved for human consumption. It is classified as a research compound and permitted for laboratory use only.
What does SR9009 do in research?
SR-9009 acts as a REV-ERBα agonist. It influences circadian rhythm regulation, energy metabolism, and mitochondrial activity in research subjects.
What are the reported research observations of SR-9009 Stenabolic?
Studies in test models have reported reductions in fat mass, improvements in dyslipidemia and hyperglycemia, and increased energy expenditure.
What are the unwanted effects of SR-9009 in research?
SR-9009 is reported to cause alterations in liver enzymes, cholesterol levels and may have an impact on circadian rhythm regulation in research.
What is the bioavailability of SR-9009 Injectable in research?
SR-9009 Injectable has higher bioavailability. Injectable delivery bypasses first-pass metabolism and allows for more consistent plasma levels in research.
How should SR-9009 Stenabolic be stored?
SR-9009 Injectable should be stored at 2–8 °C in a dark place to maintain its stability and integrity.
Where can readers find vendor information for SR-9009 Stenabolic Injectable?
Iron Mountain Labz provides research information and affiliate purchasing pathways but does not directly sell, manufacture, warehouse, or ship SR-9009 Stenabolic Injectable. Readers should assess third-party suppliers independently and review available identity, purity, and batch-testing documentation.
IML Affiliate Disclosure
Some links on IML may connect readers with third-party suppliers through affiliate arrangements. IML may receive compensation from qualifying transactions at no additional cost to the reader, but the third-party supplier remains responsible for the actual sale, fulfillment, and product documentation.
